ইউরোপীয় ইউনিয়ন -
সুইডিশ -
EMA (European Medicines Agency)
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - klopidogrelbesilat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotiska medel - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st-segmentet höjd akut hjärtinfarkt, i kombination med asa i medicinskt behandlade patienter berättigade till trombolysbehandling. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. för ytterligare information hänvisas till avsnitt 5.
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
duloxetine accordpharma 20 mg enterokapsel, hård
accord healthcare b.v. - duloxetinhydroklorid - enterokapsel, hård - 20 mg - duloxetinhydroklorid 22,433 mg aktiv substans; sockersfärer hjälpämne; natriumlaurilsulfat hjälpämne; sackaros hjälpämne; propylenglykol hjälpämne
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
duloxetine accordpharma 40 mg enterokapsel, hård
accord healthcare b.v. - duloxetinhydroklorid - enterokapsel, hård - 40 mg - natriumlaurilsulfat hjälpämne; sackaros hjälpämne; sockersfärer hjälpämne; duloxetinhydroklorid 44,866 mg aktiv substans; propylenglykol hjälpämne
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
pregabalin aliud pharma 100 mg kapsel, hård
aliud pharma gmbh - pregabalin - kapsel, hård - 100 mg - laktosmonohydrat hjälpämne; pregabalin 100 mg aktiv substans
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
pregabalin aliud pharma 225 mg kapsel, hård
aliud pharma gmbh - pregabalin - kapsel, hård - 225 mg - laktosmonohydrat hjälpämne; pregabalin 225 mg aktiv substans
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
pregabalin aliud pharma 200 mg kapsel, hård
aliud pharma gmbh - pregabalin - kapsel, hård - 200 mg - laktosmonohydrat hjälpämne; pregabalin 200 mg aktiv substans
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
pregabalin aliud pharma 150 mg kapsel, hård
aliud pharma gmbh - pregabalin - kapsel, hård - 150 mg - laktosmonohydrat hjälpämne; pregabalin 150 mg aktiv substans
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
pregabalin aliud pharma 300 mg kapsel, hård
aliud pharma gmbh - pregabalin - kapsel, hård - 300 mg - pregabalin 300 mg aktiv substans; laktosmonohydrat hjälpämne
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
pregabalin aliud pharma 25 mg kapsel, hård
aliud pharma gmbh - pregabalin - kapsel, hård - 25 mg - pregabalin 25 mg aktiv substans; laktosmonohydrat hjälpämne
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
pregabalin aliud pharma 50 mg kapsel, hård
aliud pharma gmbh - pregabalin - kapsel, hård - 50 mg - pregabalin 50 mg aktiv substans; laktosmonohydrat hjälpämne